Membership
SITC is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy. As a member, you will join a growing network of nearly 1,300 basic and translational scientists, practitioners, government leaders and industry professionals worldwide.
A SITC membership offers opportunities to catalyze your research, to create new connections across sectors and to contribute to cutting-edge scientific endeavors. As a member-driven society, SITC members collaborate to create important educational and networking events, publications and resources that are valuable to researchers, scientists, clinicians and patients alike. Whether you are a young investigator or luminary in the field, SITC membership can help you meet your goals while advancing the science and application of cancer immunotherapy.
As a SITC member, you are eligible to:
- Serve on SITC's Board of Directors (Regular members only)
- Present at SITC educational programs and activities, and lead and shape discussions that guide progress in the field
- Serve in leadership roles and sit on SITC committees charged with representing the best interests of the Society and serving as champions for the field
In addition to these personal and professional advancement opportunities, all SITC members receive:
- Waived article processing charges when you submit research to the Journal for ImmunoTherapy of Cancer (JITC)—SITC’s official open access, peer reviewed journal
- Reduced registration rates for all SITC educational programs and activities, including our Annual Meeting & Associated Programs
- Access to our membership directory, available only through the “Members Only” section of our website
- Free access to speaker presentations and slide decks from archived SITC live events
- Discounts on SITC enduring materials
Young investigators and early career scientists are also eligible for Young Investigator Abstract Travel and Presidential Awards.
Our Mission
It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Core Values
Interaction/Integration: Facilitate the exchange of information and education among basic and translational researchers, clinicians, young investigators, societies and groups sharing the mission of SITC
Innovation: Challenge the thinking and seek the best research in the development of cancer immunotherapy
Translation: Facilitate the transfer of cancer immunology and immunotherapy research from the bench to the clinic and back
Leadership: Define what is new and important and effectively communicate it to all relevant stakeholders
